
Guangzhou Pharma Graft: 17 Executives Sentenced in RMB200m Corruption and Fakeâdrug Ring
Chinaâs Guangzhou Pharmaceutical Group has publicly announced the conviction or disciplining of 17 executives in a corruption probe involving more than RMB200 million. The cases, which include bribery, kickbacks and the sale of counterfeit medicines, focus heavily on advertising, procurement and distribution channels within the stateâowned group and its Wanglaoji subsidiary.


















